The population pharmacokinetics of long‐term methotrexate in rheumatoid arthritis

Abstract

The population pharmacokinetics of methotrexate in adults with rheumatoid arthritis were well described by this investigation. Substantial interpatient variability was explained by incorporating patient specific data into regression equations predicting pharmacokinetic parameters.